These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 19226329)

  • 41. Factors associated with hepatic fibrosis in patients with chronic hepatitis C: a retrospective study of a large cohort of U.S. patients.
    Hu SX; Kyulo NL; Xia VW; Hillebrand DJ; Hu KQ
    J Clin Gastroenterol; 2009 Sep; 43(8):758-64. PubMed ID: 19238091
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Introducing the CPL/MUW proteome database: interpretation of human liver and liver cancer proteome profiles by referring to isolated primary cells.
    Wimmer H; Gundacker NC; Griss J; Haudek VJ; Stättner S; Mohr T; Zwickl H; Paulitschke V; Baron DM; Trittner W; Kubicek M; Bayer E; Slany A; Gerner C
    Electrophoresis; 2009 Jun; 30(12):2076-89. PubMed ID: 19582709
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Alterations in rat serum proteome and metabolome as putative disease markers in sepsis.
    Hinkelbein J; Feldmann RE; Schubert C; Peterka A; Schelshorn D; Maurer MH; Kalenka A
    J Trauma; 2009 Apr; 66(4):1065-75. PubMed ID: 19359916
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Differentially expressed serum haptoglobin alpha chain isoforms with potential application for diagnosis of head and neck cancer.
    Chen CB; Su YC; Huang TT; Ho HC; Chang YT; Tung YT; Lee WC
    Clin Chim Acta; 2008 Dec; 398(1-2):48-52. PubMed ID: 18727923
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Serum proteomic analysis focused on fibrosis in patients with hepatitis C virus infection.
    White IR; Patel K; Symonds WT; Dev A; Griffin P; Tsokanas N; Skehel M; Liu C; Zekry A; Cutler P; Gattu M; Rockey DC; Berrey MM; McHutchison JG
    J Transl Med; 2007 Jul; 5():33. PubMed ID: 17625010
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A proteomics approach to identify changes in protein profiles in serum of Familial Adenomatous Polyposis patients.
    Quaresima B; Crugliano T; Gaspari M; Faniello MC; Cosimo P; Valanzano R; Genuardi M; Cannataro M; Veltri P; Baudi F; Doldo P; Cuda G; Venuta S; Costanzo F
    Cancer Lett; 2008 Dec; 272(1):40-52. PubMed ID: 18667268
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Two-dimensional difference gel electrophoresis (DiGE) analysis of plasmas from dengue fever patients.
    Albuquerque LM; Trugilho MR; Chapeaurouge A; Jurgilas PB; Bozza PT; Bozza FA; Perales J; Neves-Ferreira AG
    J Proteome Res; 2009 Dec; 8(12):5431-41. PubMed ID: 19845402
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Serum leucine-rich alpha-2-glycoprotein-1 binds cytochrome c and inhibits antibody detection of this apoptotic marker in enzyme-linked immunosorbent assay.
    Cummings C; Walder J; Treeful A; Jemmerson R
    Apoptosis; 2006 Jul; 11(7):1121-9. PubMed ID: 16699948
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serum proteome alteration of severe sepsis in the treatment of continuous renal replacement therapy.
    Gong Y; Chen N; Wang FQ; Wang ZH; Xu HX
    Nephrol Dial Transplant; 2009 Oct; 24(10):3108-14. PubMed ID: 19461007
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Proteome maps of the main human peripheral blood constituents.
    Haudek VJ; Slany A; Gundacker NC; Wimmer H; Drach J; Gerner C
    J Proteome Res; 2009 Aug; 8(8):3834-43. PubMed ID: 19580323
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serum proteomics of hepatitis C virus infection reveals retinol-binding protein 4 as a novel regulator.
    Gouthamchandra K; Kumar A; Shwetha S; Mukherjee A; Chandra M; Ravishankar B; Khaja MN; Sadhukhan PC; Das S
    J Gen Virol; 2014 Aug; 95(Pt 8):1654-1667. PubMed ID: 24784414
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Quantitative assessment of human serum high-abundance protein depletion.
    Stempfer R; Kubicek M; Lang IM; Christa N; Gerner C
    Electrophoresis; 2008 Nov; 29(21):4316-23. PubMed ID: 18956433
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Is there any non-invasive marker replace the needle liver biopsy predictive for liver fibrosis, in patients with chronic hepatitis?
    Vardar R; Vardar E; Demiri S; Sayhan SE; Bayol U; Yildiz C; Postaci H
    Hepatogastroenterology; 2009; 56(94-95):1459-65. PubMed ID: 19950810
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identifying candidate serum biomarkers of exposure to tunicamycins in rats using two-dimensional electrophoresis.
    Penno MA; Bacic A; Colegate SM; Hoffmann P; Michalski WP
    J Proteome Res; 2009 Jun; 8(6):2812-26. PubMed ID: 19317491
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of serum percent trisialotransferrin as potential predictive biomarker of hepatocellular dedifferentiation in chronic liver disease.
    Gressner OA; Jafari S; Erkens M; Gao C; Stanzel S; Gressner AM
    Clin Chim Acta; 2009 May; 403(1-2):188-93. PubMed ID: 19281805
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Transcriptional Dysregulation of Upstream Signaling of IFN Pathway in Chronic HCV Type 4 Induced Liver Fibrosis.
    Ibrahim MK; Salum GM; Bader El Din NG; Dawood RM; Barakat A; Khairy A; El Awady MK
    PLoS One; 2016; 11(5):e0154512. PubMed ID: 27135246
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of proteomics in the investigation of pulmonary fibrosis.
    Govender P; Baugh JA; Pennington SR; Dunn MJ; Donnelly SC
    Expert Rev Proteomics; 2007 Jun; 4(3):379-88. PubMed ID: 17552922
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Transient elastography and other noninvasive tests to assess hepatic fibrosis in patients with viral hepatitis.
    Castera L
    J Viral Hepat; 2009 May; 16(5):300-14. PubMed ID: 19254351
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Novel biomarkers predict liver fibrosis in hepatitis C patients: alpha 2 macroglobulin, vitamin D binding protein and apolipoprotein AI.
    Ho AS; Cheng CC; Lee SC; Liu ML; Lee JY; Wang WM; Wang CC
    J Biomed Sci; 2010 Jul; 17(1):58. PubMed ID: 20630109
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.
    de Arias AE; Haworth SE; Belli LS; Burra P; Pinzello G; Vangeli M; Minola E; Guido M; Boccagni P; De Feo TM; Torelli R; Cardillo M; Scalamogna M; Poli F
    Liver Transpl; 2009 Apr; 15(4):390-9. PubMed ID: 19326408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.